Trial intelligence / Profile preview

Manufacturing Scale vs Pilot Scale 13vPnC in Infants

NCT00464945Phase 3Completed

Sponsor
Pfizer
Start
Jun 2007
Primary completion
Sep 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started Jun 2007; status: completed.

02

Drugs

Prevnar 13
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00464945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00464945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call